C4 THERAPEUTICS INC's ticker is CCCC and the CUSIP is 12529R107. A total of 116 filers reported holding C4 THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $84,334 | -8.9% | 45,341 | +34.7% | 0.00% | – |
| Q2 2023 | $92,589 | -42.7% | 33,669 | -34.6% | 0.00% | – |
| Q1 2023 | $161,672 | -86.0% | 51,488 | -73.6% | 0.00% | – |
| Q4 2022 | $1,151,420 | -5.7% | 195,156 | +40.2% | 0.00% | – |
| Q3 2022 | $1,221,000 | +163.1% | 139,187 | +126.3% | 0.00% | – |
| Q2 2022 | $464,000 | -81.6% | 61,511 | -40.7% | 0.00% | – |
| Q1 2022 | $2,517,000 | -23.1% | 103,778 | +2.1% | 0.00% | – |
| Q4 2021 | $3,274,000 | +240.0% | 101,673 | +371.8% | 0.00% | – |
| Q3 2021 | $963,000 | -25.8% | 21,551 | -37.2% | 0.00% | – |
| Q2 2021 | $1,298,000 | -28.0% | 34,305 | -29.7% | 0.00% | – |
| Q1 2021 | $1,804,000 | +788.7% | 48,774 | +695.7% | 0.00% | – |
| Q4 2020 | $203,000 | – | 6,130 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 1,642,210 | $14,402,000 | 1.72% |
| Soleus Capital Management, L.P. | 1,441,513 | $12,642,000 | 1.72% |
| Nextech Invest Ltd. | 375,857 | $3,296,000 | 1.06% |
| RTW INVESTMENTS, LP | 2,819,472 | $24,727,000 | 0.57% |
| ArrowMark Colorado Holdings LLC | 5,091,975 | $44,657,000 | 0.55% |
| WASATCH ADVISORS LP | 5,934,476 | $52,045,000 | 0.36% |
| HARBOR CAPITAL ADVISORS, INC. | 25,470 | $223,000 | 0.20% |
| Perceptive Advisors | 766,231 | $6,720,000 | 0.20% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 606,721 | $5,321,000 | 0.08% |
| Virtus ETF Advisers LLC | 19,305 | $169,000 | 0.07% |